MedPath

Acquisition of optical and olfactory sensory impressions directly during radiation therapy with protons or photons

Conditions
C00-C14
C15-C26
C30-C39
C40-C41
C43-C44
C45-C49
C50
C51-C58
C60-C63
C64-C68
Registration Number
DRKS00021817
Lead Sponsor
niversitätsklinikum und Medizinische Fakultät Carl Gustav Carus der Technischen Universität Dresden, Klinik und Poliklinik für Strahlentherapie und Radioonkologie
Brief Summary

There were 37% of the patients experiencing phantosmias, 51% experiencing phosphenes, and 29% simultaneously experiencing both sensations. Phosphenes were typically perceived as a ?ashily blue, white and/or purple light, phantosmias were typically perceived as a chemical-like, metallic or burnt smell. Younger age (F= 7.81, p< 0.01), radiation in the brain region (?2 = 14.05, p= 0.02), absence of taste problems (?2 = 10.28, p= 0.01), and proton RT (?2 = 10.57, p= 0.01) were related to these abnormal sensations. History of chemical/dust exposure predicted lower intensity (B= –1.52, p= 0.02) and lower unpleasantness (B= 0.49, p= 0.03) of phantosmia. In contrast, disease (tumor) duration (B= 0.11, p< 0.01), food allergy (B= 2.77, p< 0.01), and epilepsy (B= –1.50, p= 0.02) in?uence phosphenes intensity. Analgesics intake predicted a higher pleasantness of the phosphenes (B= 0.47, p< 0.01).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
106
Inclusion Criteria

Age >18 years
- planned proton or photon therapy with a local ablative radiation dose
- oral and written consent
- adequate general condition

Exclusion Criteria

- poor German language skills
- palliative treatment concept
- Participation in an intervention study whose procedures conflict with the present study

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of visual and olfactory perception during radiation
Secondary Outcome Measures
NameTimeMethod
Comparison of patient cohorts regarding cofactors, radiation therapy, dose volume histogram-analysis
© Copyright 2025. All Rights Reserved by MedPath